Correlation Between Leap Therapeutics and Spruce Biosciences
Can any of the company-specific risk be diversified away by investing in both Leap Therapeutics and Spruce Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Leap Therapeutics and Spruce Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Leap Therapeutics and Spruce Biosciences, you can compare the effects of market volatilities on Leap Therapeutics and Spruce Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Leap Therapeutics with a short position of Spruce Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Leap Therapeutics and Spruce Biosciences.
Diversification Opportunities for Leap Therapeutics and Spruce Biosciences
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Leap and Spruce is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Leap Therapeutics and Spruce Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spruce Biosciences and Leap Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Leap Therapeutics are associated (or correlated) with Spruce Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spruce Biosciences has no effect on the direction of Leap Therapeutics i.e., Leap Therapeutics and Spruce Biosciences go up and down completely randomly.
Pair Corralation between Leap Therapeutics and Spruce Biosciences
Given the investment horizon of 90 days Leap Therapeutics is expected to generate 1.55 times more return on investment than Spruce Biosciences. However, Leap Therapeutics is 1.55 times more volatile than Spruce Biosciences. It trades about 0.05 of its potential returns per unit of risk. Spruce Biosciences is currently generating about -0.04 per unit of risk. If you would invest 248.00 in Leap Therapeutics on September 1, 2024 and sell it today you would earn a total of 50.00 from holding Leap Therapeutics or generate 20.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Leap Therapeutics vs. Spruce Biosciences
Performance |
| Timeline |
| Leap Therapeutics |
| Spruce Biosciences |
Leap Therapeutics and Spruce Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Leap Therapeutics and Spruce Biosciences
The main advantage of trading using opposite Leap Therapeutics and Spruce Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Leap Therapeutics position performs unexpectedly, Spruce Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spruce Biosciences will offset losses from the drop in Spruce Biosciences' long position.| Leap Therapeutics vs. X4 Pharmaceuticals | Leap Therapeutics vs. Terns Pharmaceuticals | Leap Therapeutics vs. Day One Biopharmaceuticals | Leap Therapeutics vs. PDS Biotechnology Corp |
| Spruce Biosciences vs. Inozyme Pharma | Spruce Biosciences vs. Day One Biopharmaceuticals | Spruce Biosciences vs. Terns Pharmaceuticals | Spruce Biosciences vs. Eledon Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |